Literature DB >> 28724496

Effects of Time and Storage Conditions on the Chemical and Microbiologic Stability of Diluted Buprenorphine for Injection.

Johnathan M DenHerder1, Ralph L Reed2, Jennifer L Sargent3, Gerd Bobe4, Jan F Stevens2, Helen E Diggs3.   

Abstract

Buprenorphine is a partial μ-opioid agonist used for analgesia. Due to the small size of laboratory rodents, buprenorphine HCl is typically diluted 10- or 20-fold with a sterile diluent, such as saline, for accurate dosing. Protocols for preparing and storing diluted buprenorphine vary by institution, and little published information is available regarding stability and beyond-use dating of specific buprenorphine preparations. The purpose of this study was to determine the chemical and microbiologic stability of diluted buprenorphine stored for a maximum of 180 d. Buprenorphine HCl was diluted 1:10 into sterile bacteriostatic saline by using aseptic technique. Diluted samples were stored in glass vials or plastic syringes, protected from light, and maintained at refrigerated or room temperature for as long as 180 d. Aerobic and anaerobic cultures on all stored samples were negative for bacterial and fungal growth. According to HPLC analysis, diluted buprenorphine stored in glass vials experienced less than 10% loss when stored for 180 d at either refrigerated or room temperature. However, the concentration of buprenorphine stored in syringes declined rapidly to more than 80% loss at room temperature and 28% loss in the refrigerator after 180 d. According to the results of this study, diluted buprenorphine stored in glass vials retains more than 90% of the initial concentration and is microbiologically stable for 180 d. However, our data suggest that, regardless of the duration, storing diluted buprenorphine in plastic syringes is inadvisable.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28724496      PMCID: PMC5517336     

Source DB:  PubMed          Journal:  J Am Assoc Lab Anim Sci        ISSN: 1559-6109            Impact factor:   1.232


  4 in total

1.  Stability of buprenorphine, haloperidol and glycopyrrolate mixture in a 0.9% sodium chloride solution.

Authors:  A Jäppinen; H Kokki; T J Naaranlahti; A S Rasi
Journal:  Pharm World Sci       Date:  1999-12

2.  Adsorption of radiopharmaceuticals to syringes: setting up a reliable protocol for its assessment.

Authors:  Tanja Gmeiner Stopar; Aljaz Socan; Petra Kolenc Peitl
Journal:  Nucl Med Commun       Date:  2007-12       Impact factor: 1.690

Review 3.  Evaluation of the chemical compatibility of plastic contact materials and pharmaceutical products; safety considerations related to extractables and leachables.

Authors:  Dennis Jenke
Journal:  J Pharm Sci       Date:  2007-10       Impact factor: 3.534

4.  Beyond-use date determination of buprenorphine buccal solution using a stability-indicating high-performance liquid chromatographic assay.

Authors:  Loren Madden Kirk; Stacy D Brown
Journal:  J Feline Med Surg       Date:  2015-02-13       Impact factor: 2.015

  4 in total
  4 in total

1.  Pharmacokinetics of Sustained-release and Extended-release Buprenorphine in Mice after Surgical Catheterization.

Authors:  Marissa Saenz; Elizabeth A Bloom-Saldana; Tim Synold; Richard W Ermel; Patrick T Fueger; James B Finlay
Journal:  J Am Assoc Lab Anim Sci       Date:  2022-08-25       Impact factor: 1.706

2.  Sterility of Sustained-release Buprenorphine.

Authors:  Shraddha I Cantara; Crystal Gergye; Vanessa K Lee; Michael Huerkamp
Journal:  J Am Assoc Lab Anim Sci       Date:  2022-01-26       Impact factor: 1.706

3.  Sterility and Stability of Diluted Meloxicam in Compounded Multi-dose Vial after 365 Days.

Authors:  Hironori K Kawano; Gregory D Simonek; Andrea D Moffitt; John M Tahara; Andlaurie L Brignolo
Journal:  J Am Assoc Lab Anim Sci       Date:  2019-08-05       Impact factor: 1.232

Review 4.  Current Topics in Marmoset Anesthesia and Analgesia.

Authors:  Anna Goodroe; Casey Fitz; Jaco Bakker
Journal:  ILAR J       Date:  2020-12-31       Impact factor: 1.521

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.